Literature DB >> 22787430

CD4+ and CD8+ T-cell skewness in classic Kaposi sarcoma.

Antonio Galleu1, Claudio Fozza, Maria Pina Simula, Salvatore Contini, Patrizia Virdis, Giovanna Corda, Simonetta Pardini, Francesca Cottoni, Sara Pruneddu, Antonio Angeloni, Simona Ceccarelli, Maurizio Longinotti.   

Abstract

It is widely accepted that a deranged immune system plays a key role in the onset and evolution of classic Kaposi sarcoma (CKS). Nevertheless, the usage of the T-cell receptor (TCR) β-variable (BV) chain repertoire expressed by peripheral blood lymphocytes in patients with CKS is still unknown. With the aim of providing some further insights into the complex role of the immune system in CKS pathogenesis, we performed an extensive analysis of the TCR BV repertoire in both CD4(+) and CD8(+) T cells in 30 human herpesvirus 8-positive Sardinian patients with CKS and an equal number of age-matched healthy controls. We used a panel of monoclonal antibodies covering approximately 70% of human BV subfamilies and third complementarity determining region (CDR3) spectratyping. Patients with CKS showed an increased frequency of BV expansions in both CD4(+) and CD8(+) lymphocytes, with no prevalent clones. On spectratyping analysis, most of the 720 BV CDR3 profiles obtained from both CD4(+) and CD8(+) T cells in patients with CKS were skewed. In particular, the surprising increase of BV skewing observed in CD4(+) lymphocytes mimics the pattern of progressive TCR BV narrowing described in responses to persistent viral antigen stimulations. Our findings support the hypothesis that CKS evolution is associated with inadequate activation rather than impairment of the immune system.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22787430      PMCID: PMC3394191          DOI: 10.1596/neo.11646

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  38 in total

1.  Flow cytometric analysis of the Vbeta repertoire in healthy controls.

Authors:  R van den Beemd; P P Boor; E G van Lochem; W C Hop; A W Langerak; I L Wolvers-Tettero; H Hooijkaas; J J van Dongen
Journal:  Cytometry       Date:  2000-08-01

2.  The shaping of the T cell repertoire.

Authors:  M Correia-Neves; C Waltzinger; D Mathis; C Benoist
Journal:  Immunity       Date:  2001-01       Impact factor: 31.745

3.  Regression of AIDS-related Kaposi's sarcoma following antiretroviral therapy with protease inhibitors: biological correlates of clinical outcome.

Authors:  A M Cattelan; M L Calabro; S M Aversa; M Zanchetta; F Meneghetti; A De Rossi; L Chieco-Bianchi
Journal:  Eur J Cancer       Date:  1999-12       Impact factor: 9.162

Review 4.  Biology of Kaposi's sarcoma.

Authors:  B Ensoli; C Sgadari; G Barillari; M C Sirianni; M Stürzl; P Monini
Journal:  Eur J Cancer       Date:  2001-07       Impact factor: 9.162

5.  Direct correlation between human herpesvirus-8 seroprevalence and classic Kaposi's sarcoma incidence in Northern Sardinia.

Authors:  R Santarelli; R De Marco; M V Masala; A Angeloni; S Uccini; R Pacchiarotti; M A Montesu; R Satta; D Cerimele; A Faggioni; F Cottoni
Journal:  J Med Virol       Date:  2001-10       Impact factor: 2.327

6.  Oligoclonal and polyclonal CD4 and CD8 lymphocytes in aplastic anemia and paroxysmal nocturnal hemoglobinuria measured by V beta CDR3 spectratyping and flow cytometry.

Authors:  Antonio M Risitano; Hoon Kook; Weihua Zeng; Guibin Chen; Neal S Young; Jaroslaw P Maciejewski
Journal:  Blood       Date:  2002-07-01       Impact factor: 22.113

7.  High frequency of the TCRBV20S1 null allele in the Sardinian population.

Authors:  Silvana Bonfigli; Claudio Fozza; Salvatore Contini; Raffaella Buzzetti; Francesco Cucca; Maurizio Longinotti
Journal:  Hum Immunol       Date:  2007-02-15       Impact factor: 2.850

8.  Kaposi's sarcoma-associated herpesvirus cytotoxic T lymphocytes recognize and target Darwinian positively selected autologous K1 epitopes.

Authors:  Justin Stebbing; Dimitra Bourboulia; Margaret Johnson; Stephen Henderson; Ian Williams; Natalie Wilder; Mervyn Tyrer; Mike Youle; Nesrina Imami; Toru Kobu; Wolfgang Kuon; Joachim Sieper; Frances Gotch; Chris Boshoff
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

Review 9.  Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 1: epidemiology, environmental predispositions, clinical manifestations, and therapy.

Authors:  Ulrich R Hengge; Thomas Ruzicka; Stephen K Tyring; Martin Stuschke; Michael Roggendorf; Robert A Schwartz; Siegfried Seeber
Journal:  Lancet Infect Dis       Date:  2002-05       Impact factor: 25.071

10.  Identification of an HLA A*0201-restricted CD8(+) T-cell epitope for the glycoprotein B homolog of human herpesvirus 8.

Authors:  Qiong J Wang; Xiao-Li Huang; Giovanna Rappocciolo; Frank J Jenkins; William H Hildebrand; Zheng Fan; Elaine K Thomas; Charles R Rinaldo
Journal:  Blood       Date:  2002-05-01       Impact factor: 22.113

View more
  6 in total

1.  Cancer subclonal genetic architecture as a key to personalized medicine.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2013-12       Impact factor: 5.715

Review 2.  Adaptive immune responses to Kaposi's sarcoma-associated herpesvirus.

Authors:  Angela Nalwoga; Denise Whitby
Journal:  Curr Opin Immunol       Date:  2022-07-08       Impact factor: 7.268

3.  Overcoming intratumor heterogeneity of polygenic cancer drug resistance with improved biomarker integration.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2012-12       Impact factor: 5.715

4.  Classic Kaposi Sarcoma: to treat or not to treat?

Authors:  Bruno Vincenzi; Loretta D'Onofrio; Anna Maria Frezza; Rosario Francesco Grasso; Valentina Fausti; Daniele Santini; Angelo Paolo Dei Tos; Giuseppe Tonini
Journal:  BMC Res Notes       Date:  2015-04-10

5.  Kaposi Sarcoma in an Human Immunodeficiency Virus (HIV)-Seronegative Mediterranean Female: Report of a Rare Case.

Authors:  Marios Grigoriou; Konstantinia E Kofina; Aristeidis Ioannidis; Domniki K Gerasimidou; Christoforos Efthymiadis; Thomas Zaramboukas
Journal:  Am J Case Rep       Date:  2017-07-26

6.  Professional antigen presenting cells in human herpesvirus 8 infection.

Authors:  Emilee R Knowlton; Lauren M Lepone; Jun Li; Giovanna Rappocciolo; Frank J Jenkins; Charles R Rinaldo
Journal:  Front Immunol       Date:  2013-01-21       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.